China's biological influenza virus split vaccine has passed pre certification by the World Health Organization
Chinese Biology20231020Chinese BiologyWHOChinese BiologyChinese BiologyThe influenza virus split vaccine produced by Changchun Institute of Biological Products has officially launched the pre certification work of the World Health Organization since 2015, and has undergone comprehensive and in-depth benchmarking with the latest international regulations and guidelines. After process changes and continuous optimization, the product quality standards have been continuously improved...
The first export of tetravalent influenza vaccine from Wuhan Institute of Biological Products of China to Africa
On the morning of October 19th, the first batch of tetravalent influenza virus split vaccine exported to Africa by China Biological Wuhan Institute of Biological Products was sent to Kenya. This vaccine is the first influenza vaccine registered in Kenya and exported for sale by China National Pharmaceutical Group's China Biotechnology...
Gene editing enables chickens to gain resistance to avian influenza
According to a biotechnology concept validation study published on the 10th in Nature Communications, scientists have successfully developed chickens with partial resistance to avian influenza using gene editing technology.Scientists have edited the ANP32A gene in chicken germ cells to limit the activity of influenza A...
United Nations agencies say the continued outbreak of avian influenza poses a risk to humans
Xinhua News Agency, Geneva, July 12 (Reporter Wang Qibing) - Three United Nations agencies jointly released a press release on the 12th, stating that avian influenza has erupted in multiple parts of the world. Although it mainly affects poultry, wild birds, and some mammals, it still poses a continuous risk to humans...